TCL Archive Two Trials Presented at ASCO Demonstrate Drop in Death Risk, Increased Survival June 24, 2011
TCL Archive FDA Plans to Discuss the Negative Trial of AstraZeneca’s Drug Iressa With the Oncologic Drugs Advisory Committee in March. January 21, 2005